Table 2 The change (%) of frequency number in genomic alterations on each chromosome by 520d-5p between mock/HLF and 7D-transfectants
From: miR-520d-5p can reduce the mutations in hepatoma cancer cells and iPSCs-derivatives
Status of frequency | chr. 1 | chr. 2 | chr. 3 | chr. 4 | chr. 5 | chr. 6 | chr. 7 | chr. 8 |
reduction | 8.5 | 9.4 | 10.8 | 7.2 | 5.4 | 14.5 | 3.7 | 10.4 |
no changes | 83.2 | 81.3 | 78.8 | 85.6 | 89.4 | 71.4 | 92.7 | 79.6 |
gain | 8.3 | 9.3 | 10.4 | 7.2 | 5.2 | 14.1 | 3.6 | 10.0 |
Status of frequency | chr. 9 | chr. 10 | chr. 11 | chr. 12 | chr. 13 | chr. 14 | chr. 15 | chr. 16 |
reduction | 3.9 | 11.4 | 9.7 | 11.0 | 3.1 | 4.8 | 4.4 | 12.5 |
no changes | 92.3 | 76.9 | 80.5 | 77.9 | 93.0 | 90.5 | 91.4 | 74.7 |
gain | 3.8 | 11.7 | 9.8 | 11.1 | 3.9 | 4.7 | 4.2 | 12.8 |
Status of frequency | chr. 17 | chr. 18 | chr. 19 | chr. 20 | chr. 21 | chr. 22 | chr. 23 | chr. X |
reduction | 9.3 | 11.0 | 4.4 | 11.6 | 20.3 | 12.5 | 3.8 | 30.7 |
no changes | 82.1 | 79.0 | 91.7 | 77.0 | 59.7 | 75.2 | 92.6 | 43.8 |
gain | 8.6 | 10.0 | 3.9 | 11.4 | 20.0 | 12.3 | 3.6 | 25.5 |